NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for Inspire Pharmaceuticals Inc


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Airship Ventures' Zeppelin Eureka Makes San Francisco Fleet Week Debut
2009 OCT 20 ... CEO Alexandra Hall. "We're excited to show the crowds what Eureka can do, as well as inspire spectators to join us aboard and experience the breathtaking views of San Francisco and ... Destinations, Vacation, Transportation, Other Travel, Manufacturin, Aviation, Sailing, Pharmaceuticals. This article was prepared by Drug Law Weekly editors from staff and other ...
Subject: Airship Ventures
Price: $3.00
*
AzaSite(R) Production Increased in Response to Erythromycin Ophthalmic Ointment Shortage
2009 SEP 28 ... Bacterial Conjunctivitis, Clinical Trial Research, Drugs, Erythromycin, FDA, Inspire Pharmaceuticals Inc., Medical Device, Ophthalmic Solution, Ophthalmology, Patents Actions, Pharmaceutical ...
Subject: InSite Vision Incorporated
Price: $3.00
*
Equifax's Tony Spinelli Named Among Security 7
2009 OCT 27 ... like the Security 7 underscore the critical importance of information security and inspire us all to put the best talent and technology to work when protecting our business ... Marketing, New York Stock Exchange, Stock Market, Technology, Telecommunications, Pharmaceuticals This article was prepared by Drug Law Weekly editors from staff and other ... Equifax Inc. (NYSE:EFX) announced that Tony Spinelli, chief security officer, was named a winner of ...
Subject: Equifax Inc.
Price: $3.00
*
Former Pro and College Basketball Coach and his Transplant Surgeon Speak to Patients With Terminal Lung Disease
2009 NOV 23 ... "I am so fortunate to be able to speak at this event to inform and inspire others who are facing the death sentence I faced," said Trey Schwab, who is now an ... and family members. The event is made possible by a generous grant from Actelion Pharmaceuticals, Ltd. Keywords: Breast Cancer, Breast Carcinoma, Fibrosis, Hepatology, Lung ...
Subject: Lung Disease
Price: $3.00
*
InSite Vision Reports Third Quarter 2009 Financial Results
2009 NOV 23 ... Blepharitis, Clinical Trial Research, Drug Delivery, Drugs, Erythromycin, Inflammation, Inspire Pharmaceuticals Inc., Medical Device, Ocular Disease, Ophthalmia Neonatorum, Ophthalmic Solution, ...
Subject: InSite Vision
Price: $3.00
*
InSite Vision to Hold Annual Meeting of Stockholders
2009 OCT 19 ... in the United States and Canada and currently marketed by InSite Vision's partner, Inspire Pharmaceuticals in the United States. InSite Vision has formed multiple strategic ... in the second quarter 2009 and is being marketed by Bausch & Lomb and Pfizer Inc. InSite Vision's ophthalmic product development pipeline also includes ...
Subject: InSite Vision Incorporated
Price: $3.00
*
Inspire Completes Patient Enrollment in Three Late-Stage Clinical Trials in Cystic Fibrosis, Dry Eye and Blepharitis
2009 NOV 16 ... Clinical Trial Research, Cystic Fibrosis, Genetics, Hepatology, Inhalation Solution, Inspire Pharmaceuticals Inc., Medical Device, Pharmaceutical Business, Pharmaceutical Company, Pulmonology, Therapy, ...
Subject: Inspire Pharmaceuticals, Inc.
Price: $3.00
*
Inspire Reports Third Quarter 2009 Financial Results
2009 NOV 16 ... Elestat, Epinastine, Epinastine Hydrochloride, Erythromycin, Genetics, Hepatology, Inspire Pharmaceuticals Inc., Marketing and Licensing Agreements, Medical Device, Ophthalmic Solution, ...
Subject: Inspire Pharmaceuticals, Inc.
Price: $3.00
*
Inspire's President and CEO Christy Shaffer Receives Cystic Fibrosis Foundation's Highest Award
2009 NOV 2 ... Clinical Trials, Mental Health, Pharmaceutical, Cystic Fibrosis, Genetics, Hepatology, Inspire Pharmaceuticals Inc., Pharmaceutical Business, Pharmaceutical Company, Pulmonology,...
Subject: Inspire Pharmaceuticals, Inc.
Price: $3.00
*
InterMune Announces Collaboration With National Jewish Health on NIH-Supported Genetic Research in Idiopathic Pulmonary Fibrosis
2009 SEP 28 ... in IPF for both pirfenidone (CAPACITY trials) and Actimmune (interferon gamma-1b) (INSPIRE). The database, which includes DNA from approximately 1,500 IPF patients, ... InterMune Inc., Interferon, Interferon Gamma-1b, Marketing and Licensing Agreements, Pharmaceuticals, Respirology, Therapy, Treatment, InterMune Inc. This article was prepared ...
Subject: Fibrosis
Price: $3.00
*
Journal of Public Health Management & Practice Calls for Growth in Public Health Workforce
2009 NOV 16 ... about the field. Supplement authors also offer insights on new strategies to recruit and inspire young people to careers in health and science. "We have great optimism ... Biowarfare, Disaster Response, Infectious Diseases, Obesity, Obesity and Diabetes, Pharmaceuticals, Public Health, Terrorism, Therapy, Treatment, Wolters Kluwer Health: Lippincott ...
Subject: Public Health
Price: $3.00
*
OncoGenex Pharmaceuticals CEO Named Canada's Pacific Ernst & Young's Entrepreneur of the Year(R) in the Health Sciences Category
2009 OCT 19 ... activity among those with potential and recognizes the contribution of people who inspire others with their vision, leadership and achievement. The Ernst & Young Entrepreneur Of ... OncoGenex Pharmaceuticals, Inc. (NASDAQ:OGXI), announced that Scott Cormack, president and chief executive officer ...
Subject: Prostate Cancer
Price: $3.00
*
Philosopher Scientist Pens Premature Factulation Book, Probing Man's Proclivity to "Ignorant Certainty," with Recent Bush Presidency as an Example
2009 OCT 12 ... scientific naivete, and/or self-interest. The intent, according to Hansten, is to inspire the reader to think about Premature Factulation in politics and how future U.S. ... Politicians, Politics, Behavior, Commit, Drug Development, Drugs, Nicotine Polacrilex, Pharmaceuticals, Therapy, Treatment. This article was prepared by Biotech Business Week ...
Subject: Philoponus Press
Price: $3.00
*
SATAI Announces $1.045 Million Emerging Technology Fund Investment in Azaya Therapeutics, Inc.
2009 OCT 12 ... will provide benefits for thousands of cancer patients. About SATAI SATAI exists to Inspire technology innovation and commercialization, Create technology companies, and Grow them ... platform to produce targeted, safer and more effective formulations of chemotherapy pharmaceuticals for the treatment of cancer. "The ETF is super-charging technology ... (www.strcic.com) announced an investment of $1.045 million in Azaya Therapeutics, Inc. through the Texas Emerging Technology Fund (ETF) for the commercialization of Azaya's ...
Subject: SATAI
Price: $3.00
*
Susan Stein, CEO of CONNEXION Healthcare, Selected for the Class of 2009 Women of Distinction by Philadelphia Business Journal
2009 OCT 19 ... to developing high-quality scientific programs. Its mission is to educate, motivate, and inspire healthcare professionals across all therapeutic areas to help improve patient care. CXHC ... Keywords: Connexion Healthcare, Biotechnology Business, Biotechnology Company, Pharmaceuticals. This article was prepared by Biotech Business Week editors from staff and ...
Subject: Connexion Healthcare
Price: $3.00
*
Taseko's President & CEO Receives 'Entrepreneur of the Year' Award
2009 NOV 1 ... activity among those with potential and recognizes the contribution of people who inspire others with their vision, leadership and achievement. It celebrates those who are ... Keywords: Minerals, Mining, Mining Company, Taseko Mines Limited, Copper, Drugs, Pharmaceuticals, Therapy, Treatment. This article was prepared by Pharma Investments, ...
Subject: Taseko Mines Limited
Price: $3.00
*
The Ophthalmic Pharmaceutical Market Outlook to 2014: Competitive Landscape, Pipeline Analysis, Growth Opportunities and Market Forecasts - Now Available
2009 OCT 12 ... companies. Driven by good efficacy, Roche/Genentech's Lucentis and Allergan/Inspire's Restasis is expected to dominate the treatment of wet AMD and dry eye markets ... Ophthalmology, Patents Actions, Pfizer, Pharmaceutical Business, Pharmaceutical Company, Pharmaceuticals, Restasis, Therapy, Treatment, Xalatan, Research and Markets. This article ... Biotechnology Business, Biotechnology Company, Business, Cyclosporine, Drugs, Genentech Inc., Genetics, Glaucoma, Latanoprost, Macular Degeneration, Novartis AG, Ophthalmology, ...
Subject: Research and Markets
Price: $3.00
*
W.K. Kellogg Foundation Grant to Improve Preparation of Mich.'s Math and Science Teachers
2009 NOV 28 ... of tomorrow. The new math and science teachers who emerge from this fellowship will inspire our kids to be excited about careers in science, math and technology."The ... Teacher Education, Technology, Commit, Drugs, Nicotine Polacrilex, Pediatrics, Pharmaceuticals, Therapy, Treatment, W.K. Kellogg Foundation.This article was prepared by ...
Subject: W.K. Kellogg Foundation
Price: $3.00
*
Winners Announced in 2009 Collegiate Inventors Competition(R)
2009 NOV 2 ... Discovery, Abbott. "Through our support of the competition, Abbott hopes to help inspire today's science students who may go on to find tomorrow's cures and treatments for the ... Excimer Laser, Genetics, Medical Device, Oncology, Patent Actions, Patents Actions, Pharmaceuticals, Surgery, National Inventors Hall of Fame. This article was prepared by ...
Subject: Patents
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login